A Study to Assess the Impact of a Non-SLS Toothpaste Upon Oral Mucosal Desquamation

NCT ID: NCT03598881

Last Updated: 2018-07-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-09-19

Study Completion Date

2016-11-21

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is to compare the effect on oral mucosal desquamation of a non-SLS toothpaste and an SLS-containing toothpaste..

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Subjects will use a wash out toothpaste for at least 10 days prior to each leg of the crossover design. Clinical assessment of oral mucosa status will be performed by a trained examiner before supervised product application, 30 minutes after product application and again after 4 days of twice daily brushing with product. Supervised product application consists of cap splint application of allocated toothpaste to maxillary arch followed by brushing whole mouth with toothpaste and swishing with resultant slurry around the mouth.

For visual sloughing evaluation, the oral mucosa will be divided into 12 assessment areas and each area evaluated for severity of sloughing on a 0 to 5 scale.

The following outcomes will be generated from the sloughing data:

1. Whole mouth data per subject: each non-zero severity score will be treated as one lesion count, giving a maximum score of 12;
2. Subject level mucosal severity sloughing score: severity score averaged over the 12 areas assessed.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sloughing Skin Mucosal Inflammation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

OTHER

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Treatment

Toothpaste containing 0.32%NaF and no sodium lauryl sulphate (SLS)

Group Type EXPERIMENTAL

Treatment

Intervention Type OTHER

Comparator

Toothpaste containing 0.8% sodium monofluorophosphate (SMFP) and sodium lauryl sulphate (SLS)

Group Type ACTIVE_COMPARATOR

Treatment

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Treatment

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Internal (University of Birmingham Dental School) panellists only
2. Willing to sign an informed consent form and complete a medical history questionnaire.
3. Must be available for the duration of the study.
4. Must be a current non-smoker and not chew tobacco.
5. Have a minimum of 8 teeth in both upper and lower jaws, which are free from obvious untreated caries or significant periodontal disease

Exclusion Criteria

1. Show unwillingness, inability or lack of motivation to carry out the study procedures
2. Are pregnant or breastfeeding females.
3. Are diabetic.
4. Have severe oral mucosal problems.
5. Orthodontic banding or removable partial dentures
6. Have an active cold sore.
7. Have any oral piercings.
8. Have a mouth ulcer or who experience mouth ulcers on a regular basis, Lichen Planus Vesiculo-Bullous disorders
9. Obvious signs of untreated caries or significant periodontal disease, which in the opinion of the Study Dentist, will effect either the scientific validity of the study or if the volunteer's participation would affect their well being
10. Volunteers who are at risk from transient bacteraemias.
11. Regular use of medication, which could interfere with study objectives or affect the validity of the study.
12. Have or have had a medical or dental condition, which in the option of the dentist would make them unsuitable for inclusion.
13. Have problem of bleeding after brushing.
14. Must not be a regular user of chlorhexidine mouthwash, or have used it within the past 6 weeks.
15. Has allergic responses to dental/oral hygiene products or components in the formulation of the toothpaste.
16. The subject is participating in other studies testing oral care products.
17. The subject is an employee of Unilever.
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Birmingham

OTHER

Sponsor Role collaborator

Unilever R&D

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Iain Chapple, Professor

Role: PRINCIPAL_INVESTIGATOR

The University of Birmingham

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Birmingham

Birmingham, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ORL-OSS-2545

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Anti-gingivitis Mouthrinse
NCT06048627 COMPLETED PHASE3
Assessing Gingivitis and Plaque From a Marketed Toothpaste
NCT07158112 ACTIVE_NOT_RECRUITING PHASE4